Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (341-350 of 488) with videos related to

Pageof 49
Sort By:
Haematologica|February 17, 2022
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemiasRosa Paolillo, Mathias Boulanger, Pierre Gâtel, et al.
Oncotarget|April 11, 2015
Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changesRaynier Devillier, Véronique Mansat-De Mas, Veronique Gelsi-Boyer, et al.
Scientific Reports|September 25, 2025
Correction: CXCL10-dependent epithelial-vascular cross-talk for endothelial activation following SARS-CoV-2 infectionChaillot Laura, Blondot Marie-Lise, Recordon-Pinson Patricia, et al.
Scientific Reports|July 1, 2025
CXCL10-dependent epithelial-vascular cross-talk for endothelial activation following SARS-CoV-2 infectionChaillot Laura, Blondot Marie-Lise, Recordon-Pinson Patricia, et al.
Plos One|October 1, 2020
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidinePierre Bories, Naïs Prade, Stéphanie Lagarde, et al.
Journal of Autoimmunity|June 23, 2015
IFN-γ licenses CD11b(+) cells to induce progression of systemic lupus erythematosusNamir Shaabani, Nadine Honke, Sebastian Dolff, et al.
The European Respiratory Journal|September 4, 2024
A novel <i>in vitro</i> tubular model to recapitulate features of distal airways: the bronchioidElise Maurat, Katharina Raasch, Alexander M Leipold, et al.
Haematologica|April 22, 2011
TET2 mutations in secondary acute myeloid leukemias: a French retrospective studyOlivier Kosmider, Eric Delabesse, Véronique Mansat de Mas, et al.
Blood|December 18, 2012
The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experienceMathilde Lamarque, Sophie Raynaud, Raphael Itzykson, et al.
Scientific Reports|January 26, 2016
Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral controlVikas Duhan, Vishal Khairnar, Sarah-Kim Friedrich, et al.
Pageof 49

Showing results (341-350 of 488) with videos related to

Sort By:
Pageof 49
Haematologica|February 17, 2022
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemiasRosa Paolillo, Mathias Boulanger, Pierre Gâtel, et al.
Oncotarget|April 11, 2015
Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changesRaynier Devillier, Véronique Mansat-De Mas, Veronique Gelsi-Boyer, et al.
Scientific Reports|September 25, 2025
Correction: CXCL10-dependent epithelial-vascular cross-talk for endothelial activation following SARS-CoV-2 infectionChaillot Laura, Blondot Marie-Lise, Recordon-Pinson Patricia, et al.
Scientific Reports|July 1, 2025
CXCL10-dependent epithelial-vascular cross-talk for endothelial activation following SARS-CoV-2 infectionChaillot Laura, Blondot Marie-Lise, Recordon-Pinson Patricia, et al.
Plos One|October 1, 2020
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidinePierre Bories, Naïs Prade, Stéphanie Lagarde, et al.
Journal of Autoimmunity|June 23, 2015
IFN-γ licenses CD11b(+) cells to induce progression of systemic lupus erythematosusNamir Shaabani, Nadine Honke, Sebastian Dolff, et al.
The European Respiratory Journal|September 4, 2024
A novel <i>in vitro</i> tubular model to recapitulate features of distal airways: the bronchioidElise Maurat, Katharina Raasch, Alexander M Leipold, et al.
Haematologica|April 22, 2011
TET2 mutations in secondary acute myeloid leukemias: a French retrospective studyOlivier Kosmider, Eric Delabesse, Véronique Mansat de Mas, et al.
Blood|December 18, 2012
The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experienceMathilde Lamarque, Sophie Raynaud, Raphael Itzykson, et al.
Scientific Reports|January 26, 2016
Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral controlVikas Duhan, Vishal Khairnar, Sarah-Kim Friedrich, et al.
Pageof 49